Invalid date chosen. Displaying data for the latest date instead.

Rockwell Medical Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Rockwell Medical stocks.

Rockwell Medical Stocks Recent News

Date Stock Title
May 17 DVA BD's (BDX) FDA-Approved Test to Offer Wider Testing Access
May 16 DVA Butterfly Network (BFLY) Unveils iQ+ Bladder Ultrasound Scanner
May 16 DVA Three Reasons to Retain AMN Healthcare (AMN) Stock for Now
May 16 DVA Profound Medical (PROF) Adds AI to Prostate Cancer Treatment
May 16 ARDX Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)
May 15 DVA Centene (CNC) to Continue Serving Kansas' Medicaid Members
May 15 DVA Merit Medical (MMSI) to Expand Product Suite Via New Launch
May 15 DVA Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
May 15 DVA Senseonics' (SENS) Deal With Mercy to Drive Eversense CGM Sales
May 15 DVA Stereotaxis (STXS) Inks Deal to Buy Access Point Technologies
May 15 RMTI Rockwell Medical Inc (RMTI) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ...
May 15 RMTI Q1 2024 Rockwell Medical Inc Earnings Call
May 14 ARDX Ardelyx, Inc. Reports Employment Inducement Grants
May 14 DVA Baxter's (BAX) Clinolipid Gets FDA's Expanded Indication
May 14 DVA Glaukos (GKOS) Reaches 52-Week High: What's Aiding the Stock?
May 14 RMTI Rockwell Medical, Inc. (RMTI) Q1 2024 Earnings Call Transcript
May 14 DVA DaVita Celebrates Corporate Citizenship Achievements with Release of 2023 Community Care Report
May 14 RMTI Rockwell Medical (RMTI) Reports Q1 Loss, Tops Revenue Estimates
May 14 RMTI Rockwell Medical Non-GAAP EPS of -$0.02, revenue of $22.7M beats by $1M
May 14 RMTI Rockwell Medical Announces First Quarter 2024 Results, Raises 2024 Guidance
Rockwell Medical

Rockwell Medical Inc. is a publicly traded (NASDAQ: RMTI) biopharmaceutical company founded in 1996 in Michigan. Rockwell focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).This company performed top during 2013, among biopharmaceutical companies in the US and has two largest dialysis centers in the US, DaVita (DVA) and Fresenius (FMS), as the buyer of its products.

Browse All Tags